Spondylitis News and Research

RSS
Enbrel shown to significantly reduced levels of C-reactive protein

Enbrel shown to significantly reduced levels of C-reactive protein

Survey of rheumatic diseases in China

Survey of rheumatic diseases in China

Discovery of two genes linked to a disabling form of arthritis called ankylosing spondylitis

Discovery of two genes linked to a disabling form of arthritis called ankylosing spondylitis

Remicade helps those with ankylosing spondylitis

Remicade helps those with ankylosing spondylitis

Largest ever genetics study of common diseases

Largest ever genetics study of common diseases

Researchers shed light on the link between chronic inflammation and atherosclerosis

Researchers shed light on the link between chronic inflammation and atherosclerosis

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott opens biotech facility in Puerto Rico

Abbott opens biotech facility in Puerto Rico

New Crohn's disease treatment Humira promises to reduce symptoms

New Crohn's disease treatment Humira promises to reduce symptoms

FDA approves Humira (adalimumab) for Crohn's disease

FDA approves Humira (adalimumab) for Crohn's disease

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

NICE backs use of Enbrel and Raptiva to treat severe psoriasis

Arthritis drug wins approval for use in children with Crohn's disease

Arthritis drug wins approval for use in children with Crohn's disease

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Pfizer adds warning to Celebrex arthritis drug

Pfizer adds warning to Celebrex arthritis drug

Spinal arthritis often overlooked in children

Spinal arthritis often overlooked in children

Arthritis patients still suffer as drugs guidelines are ignored

Arthritis patients still suffer as drugs guidelines are ignored

Study suggests continuous NSAID treatment more effectively reduces X-Ray progression than intermittent treatment

Study suggests continuous NSAID treatment more effectively reduces X-Ray progression than intermittent treatment

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

500,000 patients have now been treated with REMICADE® worldwide

500,000 patients have now been treated with REMICADE® worldwide

Coronary stent drives Johnson & Johnson to record profits

Coronary stent drives Johnson & Johnson to record profits